Next live session

Current: Do small node negative HER-2 positive tumors deserve a better treatment? ^{CME accredited}

GR114 - 09 September 2010 - 18:15-19:00 CET

Expert: Ana M. Gonzalez-Angulo, M.D. Anderson Cancer Center, Houston, TX, USA
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer  

View details

Standard management of patients with chronic myeloid leukemia in the era of tirosine kinase inhibitors ^{CME accredited}

GR115 - 16 September 2010 - 18:15-19:00 CET

Expert: Santiago Pavlovsky, Clinical Research Canter - FUNDALEU, Buenos Aires, Argentina
Discussant: Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: Haemato-oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Survivorship issues and breast cancer ^{CME accredited}

GR116 - 23 September 2010 - 18:15-19:00 CET

Expert: Lesley Fallowfield, CRUK Sussex Psychosocial Oncology Group, Falmer, United Kingdom
Discussant: Maggie Wilcox, National Cancer Research Institute, London, United Kingdom
Topics: Breast cancer   Survivorship  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Cognitive consequences of breast cancer treatment ^{CME accredited}

GR117 - 30 September 2010 - 18:15-19:00 CET

Expert: Sanne Schagen, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Discussant: Tim A. Ahles, Memorial Sloan-Kettering Cancer Center, New York, USA
Topics: Breast cancer   Side effects  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Highlights of the Breast Cancer in Young Women Conference ^{CME accredited}

GR118 - 07 October 2010 - 18:15-19:00 CET

Expert: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Discussant: Stefan Aebi, University Hospital Berne, Inselspital, Berne, Switzerland
Topics: Breast cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Intra-operative radiotherapy ^{CME accredited}

GR119 - 14 October 2010 - 18:15-19:00 CET

Expert: Roberto Orecchia, European Institute of Oncology, Milano, Italy
Discussant: Jacques Bernier, Clinic of Genolier, Genolier, Switzerland
Topics: Breast cancer   Radiation oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Biomolecular markers of outcome prediction in prostate cancer ^{CME accredited}

GR120 - 21 October 2010 - 18:15-19:00 CET

Expert: Nadia Zaffaroni, IRCCS Foundation, National Cancer Institute, Milano, Italy
Discussant: Angelo Paradiso, Scientific Institute for Research and Treatment of Cancer Giovanni Paolo II , Bari, Italy
Topics: Genito-urinary cancers  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Future directions in multimodality therapy for NSCLC (News and Views article published in Nature Reviews Clinical Oncology) ^{CME accredited}

GR121 - 28 October 2010 - 18:15-19:00 CET

Expert: Anne S. Tsao, M.D. Anderson Cancer Center, Houston, TX, USA
Discussant: Martin Frueh, Cantonal Hospital, St. Gallen, Switzerland
Topics: Lung cancer   Radiation oncology   Surgical oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Treatment of triple negative breast cancer ^{CME accredited}

GR122 - 04 November 2010 - 18:15-19:00 CET

Expert: Angelo Di Leo, Misericordia e Dolce Hospital, Prato, Italy
Discussant: Lisa Carey, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, US
Topics: Breast cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

The role of PARP-inhibitors in breast and ovarian cancer ^{CME accredited}

GR123 - 11 November 2010 - 18:15-19:00 CET

Expert: Andrew Tutt, Breakthrough Breast Cancer Research Unit, King's College London School of Medicine, London, United Kingdom
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer   Gynecological cancers  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Explanations for worsening cancer survival (based on a Perspectives article of Nature Reviews Clinical Oncology) ^{CME accredited}

GR124 - 18 November 2010 - 18:15-19:00 CET

Expert: Esther de Vries, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Discussant: Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: General interest   Survivorship  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Prostate cancer: Post-operative radiotherapy ^{CME accredited}

GR125 - 25 November 2010 - 18:15-19:00 CET

Expert: Cesare Cozzarini, St. Raffaele Hospital, Milano, Italy
Topics: Genito-urinary cancers   Radiation oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Radiation and hormonal therapy in prostate cancer ^{CME accredited}

GR126 - 02 December 2010 - 18:15-19:00 CET

Expert: Mack Roach III, UCSF Comprehensive Cancer Center, San Francisco, USA
Discussant: Riccardo Valdagni, IRCCS Foundation, National Cancer Institute, Prostate Programme, Milano, Italy
Topics: Genito-urinary cancers   Radiation oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Challenges of cancer related bone disease ^{CME application in progress}

GR127 - 09 December 2010 - 18:15-19:00 CET

Expert: Sara Faithfull, Institute of Health and Medical Sciences, Guilford, United Kingdom
Topics: Supportive care  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

State-of-the-art treatment of anal cancer patients ^{CME accredited}

GR128 - 16 December 2010 - 18:15-19:00 CET

Expert: Arnaud Roth, University Hospital of Geneva, Geneva, Switzerland
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Esophagogastric cancer: New treatment approaches which will change the way we treat these patients ^{CME application in progress}

GR129 - 13 January 2011 - 18:15-19:00 CET

Expert: Andres Cervantes, Hospital Clinico Universitario, Valencia, Spain
Discussant: Florian Lordick, Clinic of Braunschweig, Braunschweig, Germany
Topics: Gastro-intestinal tumors  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Treatment of painful bone metastases (Review article of Nature Reviews Clinical Oncology) ^{CME accredited}

GR130 - 20 January 2011 - 18:15-19:00 CET

Expert: Dirk Rades, University of Lübeck, Lübeck, Germany
Discussant: Jesper Grau Eriksen, Odense University Hospital, Odense, Denmark
Topics: Pain treatment  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Primary mediastinal lymphoma ^{CME application in progress}

GR131 - 27 January 2011 - 18:15-19:00 CET

Expert: Peter W.M. Johnson, Cancer Research UK Centre, Southampton General Hospital, Southampton, United Kingdom
Discussant: Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: Haemato-oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Updates in adjuvant therapy and treatment of locally advanced pancreas cancer ^{CME application in progress}

GR132 - 03 February 2011 - 18:15-19:00 CET

Expert: Eileen OReilly, Memorial Sloan-Kettering Cancer Center, New York, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Gastro-intestinal tumors  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Treatment of patients with malignant pleural mesothelioma progressing after first-line pemetrexed-based chemotherapy ^{CME application in progress}

GR133 - 10 February 2011 - 18:15-19:00 CET

Expert: Giovanni Luca Ceresoli, Cliniche Humanitas Gavazzeni, Bergamo, Italy
Discussant: Marco Siano, Cantonal Hospital, St. Gallen, Switzerland
Topics: Mesothelioma  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Decision-making and treatment of malignant gliomas ^{CME application in progress}

GR134 - 17 February 2011 - 18:15-19:00 CET

Expert: Roger Stupp, University Hospital of Lausanne, Lausanne, Switzerland
Discussant: Olavo Feher, Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil
Topics: Head-and-neck cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Predictive models in prostate cancer ^{CME application in progress}

GR135 - 24 February 2011 - 18:15-19:00 CET

Expert: Karim Touijer, Memorial Sloan Kettering Cancer Centre, New York, USA
Discussant: Chris Parker, Institute of Cancer Research, Royal Marsden Hospital, Sutton, United Kingdom
Topics: Genito-urinary cancers  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Melanoma: State-of-the-art treatment ^{CME application in progress}

GR137 - 10 March 2011 - 18:15-19:00 CET

Expert: Michael B. Atkins, Beth Israel Deaconess Medical Center, Boston, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: Melanoma  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Non-small cell lung cancer in the elderly: concomittant vs. sequential vs. Radiation alone ^{CME application in progress}

GR138 - 17 March 2011 - 18:15-19:00 CET

Expert: Dirk de Ruysscher, University Hospital Maastricht, Maastricht, The Netherlands
Topics: Lung cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Amyloidosis and neoplasia ^{CME application in progress}

GR139 - 24 March 2011 - 18:15-19:00 CET

Expert: Giampaolo Merlini, IRCCS Fondation, Policlinico San Matteo, Pavia, Italy
Topics: Amyloidosis  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Advances in the treatment of promyelocytic leukaemia ^{CME application in progress}

GR140 - 31 March 2011 - 18:15-19:00 CET

Expert: Miguel Sanz, Hospital Universitario La Fe, Valencia, Spain
Topics: Leukaemia  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Hodgkin lymphoma: State-of-the-art and development of personalised therapies (including the Review article published in Nature Review Clinical Oncology) ^{CME application in progress}

GR142 - 14 April 2011 - 18:15-19:00 CET

Expert: Volker Diehl, University of Cologne, Cologne, Germany
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: Haemato-oncology  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Prognostic and predictive markers in colorectal cancer: Implications for clinical management ^{CME application in progress}

GR144 - 28 April 2011 - 18:15-19:00 CET

Expert: Sabine Tejpar, University Hospital Gasthuisberg, Leuven, Belgium
Topics: Colorectal cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

ECCLU Keynote lecture: New developments in the systemic treatment of advanced prostate cancer ^{CME application in progress}

GR146 - 12 May 2011 - 18:15-19:00 CET

Expert: Ian Tannock, Princess Margaret Hospital, Toronto, Canada
Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland
Topics: Genito-urinary cancers  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Focal therapy in prostate cancer ^{CME application in progress}

GR156 - 21 July 2011 - 18:15-19:00 CET

Expert: John F. Ward, MD Anderson Cancer Center, Houston, USA
Topics: Genito-urinary cancers  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---

Advanced Breast Cancer First Consensus Conference: Highlights and guidelines ^{CME application in progress}

GR177 - 15 December 2011 - 18:15-19:00 CET

Expert: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer  

View details / Submit your question in advance

Your email (Mandatory field):
Your question:

---